Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Thomas-Delecourt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Cardiovascular Diseases|July 30, 2011
Assessment of cardiovascular risk in primary care patients in FranceEric Bruckert, Geneviève Bonnelye, Florence Thomas-Delecourt, et al.
European Journal of Pediatrics|August 21, 2012
Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational studyLéonie Martigne, Pierre-Henri Delaage, Florence Thomas-Delecourt, et al.
Journal of Vascular Surgery|March 6, 2018
Outcomes and management costs of peripheral arterial disease in FranceAlessandra Bura Riviere, Stéphane Bouée, Caroline Laurendeau, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 27, 2017
The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological StudyBeverley Balkau, Bernard Charbonnel, Alfred Penfornis, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims databasePatrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
Angiology|November 27, 2021
Mortality, Cardiovascular and Limb Events in Patients With Symptomatic Lower Extremity Artery Disease and DiabetesFrançois-Xavier Lapébie, Vanina Bongard, Philippe Lacroix, et al.
Cardiovascular Diabetology|November 26, 2021
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims databasePatrick Blin, Patrice Darmon, Patrick Henry, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Cardiovascular Diabetology|January 9, 2024
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databasePatrick Blin, Michael Joubert, Patrick Jourdain, et al.
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Cardiovascular Diseases|July 30, 2011
Assessment of cardiovascular risk in primary care patients in FranceEric Bruckert, Geneviève Bonnelye, Florence Thomas-Delecourt, et al.
European Journal of Pediatrics|August 21, 2012
Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational studyLéonie Martigne, Pierre-Henri Delaage, Florence Thomas-Delecourt, et al.
Journal of Vascular Surgery|March 6, 2018
Outcomes and management costs of peripheral arterial disease in FranceAlessandra Bura Riviere, Stéphane Bouée, Caroline Laurendeau, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 27, 2017
The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological StudyBeverley Balkau, Bernard Charbonnel, Alfred Penfornis, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims databasePatrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
Angiology|November 27, 2021
Mortality, Cardiovascular and Limb Events in Patients With Symptomatic Lower Extremity Artery Disease and DiabetesFrançois-Xavier Lapébie, Vanina Bongard, Philippe Lacroix, et al.
Cardiovascular Diabetology|November 26, 2021
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims databasePatrick Blin, Patrice Darmon, Patrick Henry, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Cardiovascular Diabetology|January 9, 2024
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databasePatrick Blin, Michael Joubert, Patrick Jourdain, et al.
Therapie|March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databasesDriss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Pageof 2